← SynDRA
WZ-4002
SynDRA canonical compound SYN0086634 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ERBB2 |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
- EGFR
- ERBB2
- BLK
- BTK
- ERBB4
- ITK
- NUAK1
Mechanisms of action (all sources)
- EGFR INHIBITOR
- BLK INHIBITOR
- BTK INHIBITOR
- ERBB4 INHIBITOR
- ITK INHIBITOR
- NUAK1 INHIBITOR
Cross-references
Synonyms
- 0UN
- WZ4002
- WZ-3146
- WZ-8040
- EGFR-T790M kinase inhibitors (lung cancer)
- EGFR-T790M kinase inhibitors (lung cancer), Gatekeeper Pharmaceuticals
- CHEBI:61400
- 6BQ432Z61M
- RefChem:195086
- DTXCID1075721
- SMR001913510
- C25H27ClN6O3
- UNII-6BQ432Z61M
- MFCD16621244
- SCHEMBL93699
- MLS003230945
- MLS006011213
- GTPL9176
- orb1300949
- SCHEMBL29354966
- SCHEMBL29733655
- EX-A416
- HMS3265O15
- HMS3265O16
- HMS3265P15
- HMS3265P16
- HMS3654C16
- BDBM50383274
- NSC755927
- s1173
- AKOS025401946
- CCG-264847
- CS-0167
- EBC-224042
- NSC-755927
- SB19360
- SDCCGSBI-0654354.P001
- WZ4002?
- NCGC00263144-01
Look up WZ-4002 in the interactive SynDRA portal →